The wide spectrum of spinocerebellar ataxias (SCAs)

Spinocerebellar ataxias (SCAs) are a clinically heterogeneous group of disorders. Current molecular classification corresponds to the order of gene description (SCA1-SCA 25). The prevalence of SCAs is estimated to be 1–4/100.000. Patients exhibit usually a slowly progressive cerebellar syndrome with various combinations of oculomotor disorders, dysarthria, dysmetria/kinetic tremor, and/or ataxic gait. They can present also with pigmentary retinopathy, extrapyramidal movement disorders (parkinsonism, dyskinesias, dystonia, chorea), pyramidal signs, cortical symptoms (seizures, cognitive impairment/behavioral symptoms), peripheral neuropathy. SCAs are also genetically heterogeneous and the clinical diagnosis of subtypes of SCAs is complicated by the salient overlap of the phenotypes between genetic subtypes. The following clinical features have some specific values for predicting a gene defect: slowing of saccades in SCA2, ophthalmoplegia in SCA1, SCA2 and SCA3, pigmentary retinopathy in SCA7, spasticity in SCA3, dyskinesias associated with a mutation in the fibroblast growth factor 14 (FGF14) gene, cognitive impairment/behavioral symptoms in SCA17 and DRPLA, seizures in SCA10, SCA17 and DRPLA, peripheral neuropathy in SCA1, SCA2, SCA3, SCA4, SCA8, SCA18 and SCA25. Neurophysiological findings are compatible with a dying-back axonopathy and/or a neuronopathy. Three patterns of atrophy can be identified on brain MRI: a pure cerebellar atrophy, a pattern of olivopontocerebellar atrophy, and a pattern of global brain atrophy. A remarkable observation is the presence of dentate nuclei calcifications in SCA20, resulting in a low signal on brain MRI sequences. Several identified mutations correspond to expansions of repeated trinucleotides (CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 and DRPLA, CTG repeats in SCA8). A pentanucleotide repeat expansion (ATTCT) is associated with SCA10. Missense mutations have also been found recently. Anticipation is a main feature of SCAs, due to instability of expanded alleles. Anticipation may be particularly prominent in SCA7. It is estimated that extensive genetic testing leads to the identification of the causative gene in about 60–75 % of cases. Our knowledge of the molecular mechanisms of SCAs is rapidly growing, and the development of relevant animal models of SCAs is bringing hope for effective therapies in human.

[1]  Christian Dina,et al.  A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3‐p15.1 , 2002, Annals of neurology.

[2]  O. Rascol,et al.  Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. , 2000, American journal of human genetics.

[3]  Thorsten Schmidt,et al.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.

[4]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.

[5]  R. Anney,et al.  Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant , 2003, Neurobiology of Disease.

[6]  A. Harding.  The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. , 1982, Brain : a journal of neurology.

[7]  J. Vincent,et al.  Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. , 2004, American journal of human genetics.

[8]  R. Sinke,et al.  Spinocerebellar ataxias in the Netherlands: Prevalence and age at onset variance analysis , 2002, Neurology.

[9]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[10]  Michael Fetter,et al.  Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2 , 2004, Annals of neurology.

[11]  H. Orr,et al.  Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11 , 1994, Nature Genetics.

[12]  S. Kustermann,et al.  Hereditary ataxias and paraplegias in Valle ďAosta, Italy: a study of prevalence and disability , 1995, Acta neurologica Scandinavica.

[13]  P. Coutinho,et al.  Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. , 1997, Journal of clinical epidemiology.

[14]  Melvin G McInnis,et al.  Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.

[15]  Masafumi Ogawa,et al.  Pharmacological treatments of cerebellar ataxia , 2008, The Cerebellum.

[16]  L. Schöls,et al.  Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[17]  Takanori Yamagata,et al.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10 , 2000, Nature Genetics.

[18]  H. Zoghbi,et al.  Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. , 2001, Human molecular genetics.

[19]  S Kobayashi,et al.  A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? , 1999, Human molecular genetics.

[20]  T. Bird,et al.  An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.

[21]  T. Bird,et al.  Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32. , 2002, American journal of medical genetics.

[22]  A. Dürr,et al.  Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p , 2004, Annals of neurology.

[23]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[24]  E. Schwinger,et al.  Phenotypical variability of expanded alleles in the TATA-binding protein gene , 2003, Journal of Neurology.

[25]  M. Leppert,et al.  Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. , 1996, American journal of human genetics.

[26]  Bing-Wen Soong,et al.  A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. , 2003, Brain : a journal of neurology.

[27]  Elmar Krieger,et al.  A Mutation in the Fibroblast Growth Factor 14 Gene Is Associated with Autosomal Dominant Cerebral Ataxia , 2003 .

[28]  Melanie Bahlo,et al.  Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. , 2004, Brain : a journal of neurology.

[29]  Y. Agid,et al.  Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion , 1997, Nature Genetics.

[30]  N. van Alfen,et al.  Peripheral nerve involvement in spinocerebellar ataxias. , 2004, Archives of neurology.

[31]  P L Pearson,et al.  Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. , 2004, Brain : a journal of neurology.

[32]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.

[33]  G. Rouleau,et al.  Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 Portuguese ataxia families. , 1998, American journal of medical genetics.

[34]  D. Housman,et al.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[36]  Elmar Krieger,et al.  A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. , 2003, American journal of human genetics.

[37]  N W Wood,et al.  Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3. , 1999, American journal of human genetics.

[38]  R. Sinke,et al.  Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21 , 2002, Human Genetics.

[39]  H Furuya,et al.  A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1 , 2001, Neurology.

[40]  H. Paulson,et al.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia , 2004, Nature Medicine.

[41]  Willibald Gerschlager,et al.  Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2 , 2003, Movement disorders : official journal of the Movement Disorder Society.

[42]  S. Tsuji,et al.  A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2‐cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4‐qter , 2000, Annals of neurology.

[43]  G. Auburger,et al.  Autosomal dominant cerebellar ataxia , 1990, Neurology.